JOHNS HOPKINS UNIVERSITY

Lobbying for JOHNS HOPKINS UNIVERSITY

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$340,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Maryland

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Budget/Appropriations

Research Funding; National Institutes of Health; Global Health Research & Development; Teen Pregnancy Prevention Program; Reconstructive Transplant Research; Agency for Healthcare Research and Quality

Health Issues

S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0

Education

P.L. 119-21, One Big Beautiful Bill Act, Federal student loan changes; Higher Education Policy; S. 5053, Accreditation Reform and Enhanced Accountability Act of 2026, Higher education accreditation;

Science/Technology

S.1296, H.R. 1048, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, DETERRENT Act;

Immigration

Immigration policy

Bills named in this filing 8

S. 2355
Patients Deserve Price Tags Act
H.R. 9599
SECURE 340B Act
S. 5244
Continuing Appropriations and Health Extenders Act of 2022
H.R. 9790
Modernizing Opioid Treatment Access Act 2.0 of 2026
S. 4941
Modernizing Opioid Treatment Access Act 2.0 of 2026
S. 5053
Accreditation Reform and Enhanced Accountability Act of 2026
S. 1296
DETERRENT Act
H.R. 1048
DETERRENT Act

Affiliated organizations 1

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

JOHNS HOPKINS HEALTH SYSTEM

Baltimore, Maryland

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.